Express Pharma

TAKE Solutions launches PVIndia

2

The network is aimed at providing a forum for the pharmaceutical industry

TAKE Solutions has launched PVIndia,a unique pharmacovigilance peer network, organised and managed by one of TAKE’s Life Sciences division, Navitas.

The benefits of nets community are open network and innovation, connection with 102 companies and 300+ global safety leaders, discussions on latest global regulatory and industry insights, peer exchange, quantitative and qualitative performance benchmark.

In continuance of its efforts to establish itself as a life sciences thought leader, TAKE Solutions has launched ‘Nets’ in India. The network is aimed at providing a forum for the pharmaceutical industry to mutually discuss and ideate onsolutions for challenges faced by them in the export market. PVINDIA is an exclusive membership based network of emerging global pharma companies from India. The network will provide a bi-annual neutral forum for heads of safety and PV leadership of global pharma companies to debate the latest subjects of interest and collaboratively generate insights on regulatory issues. Besides providing complimentary membership and access to pvtech for PV Heads of Information Technology, the platform will provide peer-to peer-comparison of PV productivity data to set new standard for the PV system in India. Furthermore, with the membership of 102 and 300+ global safety leaders participating in a year, the networks aids in exploring the value of Indian PV system in the global market. With a wide range of membership, the underlying objective of the network is to benchmark the best industry practices.

Ram Yeleswarapu, President and Chief Executive Officer, TAKE Solutions said, “We are excited about spearheading this first-of-its kind network in India. Whilst we believe that drug safety can be a source of competitive advantage, we see greater mutual benefit in the sharing of experience. Through our pharmacovigilance networks; pvnet, pvconnect, pvtech, and pvindia, our vision is to shape the future of pharmacovigilance by providing PV leaders with an environment to meet and discuss alternative solutions with other industry thought leaders for the benefit of the industry as a whole.” He further added, “As a life sciences technology services provider company, it is part of our DNA to deliver services that will aid in innovating solutions for the escalating challenges in the pharma industry. As we come together to form a community, we look forward to fostering collaboration through our network.”

EP News BureauMumbai

Comments are closed.